°øÁö

KNU School Of Medicine

°øÁö»çÇ×

Çà»ç ¹× ¼¼¹Ì³ª

°æºÏ´ëÇб³ Ư¼ºÈ­ »ç¾÷´Ü (ÀÇ»ý¸í°úÇÐ) ÃÊû ÇØ¿Ü ¼®ÇРƯ°­ °øÁö

ÆäÀÌÁö Á¤º¸

ÀÛ¼ºÀÚ °ü¸®ÀÚ ÀÛ¼ºÀÏ12-09-19 12:11 Á¶È¸4,733ȸ ´ñ±Û0°Ç

÷ºÎÆÄÀÏ

º»¹®

°æºÏ´ëÇб³ Ư¼ºÈ­ »ç¾÷´Ü (ÀÇ»ý¸í°úÇÐ) ÃÊû ÇØ¿Ü ¼®ÇРƯ°­ °øÁö

 

ÀϽÃ: 2012³â 9¿ù 24ÀÏ (¿ù) ¿ÀÈÄ 5½Ã – 7½Ã

Àå¼Ò: °æºÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø º»°ü 1Ãþ Á¦ 1 ±³¼öȸÀǽÇ

¿¬ÀÚ ¹× ¿¬Á¦

 

1) Professor Soren Nielsen (Director, Water and Salt Research Center,  University of Aarhus, Denmark)

 

¡°From aquaporin water channels in kidney to development of a new drug to prevent kidney injury associated with cardiac Surgery¡±

 

2) Professor Jorgen Frokiaer (Co- Director, Water and Salt Research Center, University of Aarhus, Denmark)

 

¡°Urinary tract obstruction induces early downregulation of AQP2: Redistribution and regulation by COX2 and Ang II¡±

 

¿¬ÀÚµéÀº ¼öºÐÅë·Î´Ü¹éÁú (aquaporin) ¿¬±¸ÀÇ ¼¼°èÀûÀÎ ¼®Çеé·Î¼­ µ§¸¶Å© ¿ÀÈĽº ´ëÇб³ (University of Aarhus) ÀÇ°ú´ëÇÐ ³» ¡°Water and Salt Research Center¡±¸¦ À¯Ä¡ÇÏ¿© Áö³­ 10³â °£ 450ÆíÀÇ °ü·Ã ³í¹®À» ¹ßÇ¥ÇÏ¿´°í, ¡°Action Pharma¡±¶ó´Â ½Å¾à°³¹ß ȸ»ç¸¦ â¾÷ÇÏ¿© °­·ÂÇÑ Ç׿°ÁõÈ¿°ú°¡ ÀÖ´Â AP214 (alpha-melanocyte stimulating hormone analogue)¸¦ °³¹ßÇÏ¿´À¸¸ç, ÃÖ±Ù ¹Ì±¹ Abbott ȸ»ç¿¡¼­ AP214¸¦ ÀμöÇÔ. À̹ø ÃÊû°­¿¬¿¡¼­´Â ¼öºÐÅë·Î´Ü¹éÁú »Ó¸¸ ¾Æ´Ï¶ó ½Å¾à°³¹ßÀÇ °æÇè¿¡ °üÇÑ °­ÀǸ¦ ÇÒ ¿¹Á¤À¸·Î, ±³¼ö´Ô°ú ¿¬±¸¿ø, Çлý ¿©·¯ºÐÀÇ ¸¹Àº Âü¿©¸¦ ºÎŹµå¸³´Ï´Ù.  

 

¹®ÀÇ: »ýÈ­Çм¼Æ÷»ý¹°Çб³½Ç ±ÇÅÂȯ ±³¼ö (420-4825, thkwon@knu.ac.kr)